Bladder Cancer More Questions Than Answers With pCR Endpoint

Bladder Cancer: More Questions Than Answers With pCR Endpoint

Pathologic complete response eventually may be a surrogate endpoint for survival, but researchers and the US FDA outlined several problems...

Original Article: Bladder Cancer: More Questions Than Answers With pCR Endpoint

More From BioPortfolio on "Bladder Cancer: More Questions Than Answers With pCR Endpoint"